The Food and Drug Administration has approved the use of a statin in people with normal cholesterol levels, in part because of evidence that taking the drug can reduce vascular inflammation.
A study found that middle-aged women who had more than two drinks per day had a slightly higher risk of developing atrial fibrillation.
Studies of a link between depression and osteoporosis suggest the bone deterioration could be a result of the depression, or may be caused by taking antidepressant medications for a long period of time.
Brief updates on the heart benefits of obesity surgery, a heart medication’s effect on bone health, and taking statins prior to heart surgery.
A study found that a year after a heart attack, about 20% of people were still suffering from angina. A program of cardiac rehabilitation can strengthen the heart and help eliminate angina’s pain.
Bystanders using defibrillators on cardiac arrest victims double their chances of survival. A new type of defibrillator provides audio guidance to help bystanders use the device properly.
Beta blockers have helped millions of people lower their blood pressure, but for people with hypertension who do not have other cardiovascular issues or symptoms, a beta blocker might not be the most effective medication.
The Food and Drug Administration offers guidelines on how to properly dispose of leftover medications.
The cholesterol-lowering drug ezetimbe, sold as Zetia and in combination with the statin Zocor as Vytorin, has proved no better at reducing plaque than the statin alone, and may be linked to an increased risk of cancer.
An FDA review of trials involving bisphosphonate drugs used to treat osteoporosis found no link between their use and any increased risk of atrial fibrillation.